MedTrace Logo

The Effects of the Endocrine System on Endometrial Cancer

NCT01075386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-08-28

No results posted yet for this study

Summary

Endometrial cancer usually begins in the endometrium, which is the tissue lining of the uterus. Endometrial cancer is the most commonly diagnosed gynaecological malignancy in Australia. It affects 1 in 80 Australian women and there are about 1400 new cases and 260 deaths from the disease every year. Most affected women are aged between 50 and 70 years. The purpose of this study is to investigate the possible role of the endocrine system in the regulation of human endometrial cancer. By looking at the laboratory results of people with endometrial cancer and also those without endometrial cancer we hope to gain a better understanding of how endometrial cancer develops and progresses. This may lead to the development of new, effective therapies for endometrial cancer.

Conditions

Sponsors & Collaborators

  • Greenslopes Private Hospital

    collaborator UNKNOWN

  • The University of Queensland

    collaborator OTHER

  • Sullivan Nicolaides Pathology

    collaborator INDUSTRY

  • Queensland Centre for Gynaecological Cancer

    lead OTHER_GOV

Principal Investigators

  • Chen Chen, MD PhD · The University of Queensland

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-08-31
Completion
2018-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01075386 on ClinicalTrials.gov